New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2019, WHO consolidated guidelines on drug-resistant tuberculosis treatment
View latest version (2019)Bibliographic information
GuidelineGuidelines for the programmatic management of drug-resistant tuberculosis - 2011 update
Year of Publication2011
Issuing InstitutionWorld Health Organization
Recommendation
Retired
In the treatment of patients newly diagnosed with multidrug-resistant tuberculosis (MDR-TB) (i.e. not previously treated for MDR-TB), a total treatment duration of 20 months is suggested for most patients, and the duration may be modified according to the patient’s response to therapy
Recommended in favor
Conditional
Certainty of evidence
Very low